Xetra

Redcare Pharmacy N.V.

HealthcareLEI 529900JK6UXHY1YKZ082Filings at the AFM Nederlands

At a glance

Most recent filing on October 16, 2026 — a grant by Schmid von Linstow P.S.L. on Oct 14, 2026.

Over the past 12 months: 0 open-market purchases and 15 open-market sales.

We hold 101 visible filings, going back to October 13, 2016.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 101 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings for this company, out of 101. Reading the whole list, and the full filer page behind every line, is part of the subscription. So are the insider score for this company, the price beside each line, the price history with every buy marked on it, any moments when several insiders bought within ninety days, and following this company. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Some of these filings come from the AFM register of board members and supervisory directors (art. 5:48 Wft). The AFM board-member register gives no transaction type; we derive it from the number of shares and the price.

Schmid von Linstow P.S.L. Board or supervisory board member
12,766 sharesGrant
TradedOct 14, 2026FiledOct 16, 2026
Holler T.M. Board or supervisory board member
€28,600Open-market sale
TradedSep 29, 2026FiledSep 29, 2026
Holler T.M. Board or supervisory board member
€28,000Open-market sale
TradedSep 29, 2026FiledSep 29, 2026
Holler T.M. Board or supervisory board member
€55,320Open-market sale
TradedSep 29, 2026FiledSep 29, 2026
Holler T.M. Board or supervisory board member
€27,220Open-market sale
TradedSep 29, 2026FiledSep 29, 2026

The insider score is a rank of the most recent scored buy, not a forecast. How it is calculated is in the methodology. Source: the Dutch AFM register (MAR art. 19).